Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Autoimmune Disorders

  Free Subscription


19.09.2022

1 Acta Neurol Scand
2 Ann Neurol
2 Brain
2 Diabet Med
2 Intern Med
1 J Autoimmun
1 J Nephrol
2 J Neuroimmunol
7 J Neurol
2 J Pediatr Endocrinol Metab
3 Kidney Int
4 N Engl J Med
1 Nat Rev Neurol
4 Neurology
1 PLoS Biol
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neurol Scand

  1. ANDREU-CARAVACA L, Ramos-Campo DJ, Chung LH, Manonelles P, et al
    Effects of fast-velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial.
    Acta Neurol Scand. 2022 Sep 9. doi: 10.1111/ane.13704.
    PubMed         Abstract available


    Ann Neurol

  2. KELLER CW, Chuquisana O, Derdelinckx J, Gross CC, et al
    Impaired B cell Expression of the Inhibitory Fcgamma Receptor IIB in Myasthenia Gravis.
    Ann Neurol. 2022 Sep 12. doi: 10.1002/ana.26507.
    PubMed         Abstract available

  3. GAUDIOSO CM, Mar S, Casper TC, Codden R, et al
    MOG and AQP4 antibodies among children with multiple sclerosis and controls.
    Ann Neurol. 2022 Sep 11. doi: 10.1002/ana.26502.
    PubMed         Abstract available


    Brain

  4. TONIETTO M, Poirion E, Lazzarotto A, Ricigliano V, et al
    Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.
    Brain. 2022 Sep 13. pii: 6696508. doi: 10.1093.
    PubMed         Abstract available

  5. TEPAVCEVIC V, Lubetzki C
    Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
    Brain. 2022 Sep 12. pii: 6696052. doi: 10.1093.
    PubMed         Abstract available


    Diabet Med

  6. FALLON C, Jones E, Oliver N, Reddy M, et al
    The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes.
    Diabet Med. 2022 Jun 25:e14906. doi: 10.1111/dme.14906.
    PubMed         Abstract available

  7. INNES CWD, Henshall DE, Wilson B, Poon MTC, et al
    Socioeconomic deprivation is associated with reduced efficacy of an insulin adjustment education program for people with type 1 diabetes.
    Diabet Med. 2022 Jun 18:e14902. doi: 10.1111/dme.14902.
    PubMed         Abstract available


    Intern Med

  8. ISAAC S, Pasha MA, Yadav U
    Immune Thrombocytopenia Following COVID-19 Vaccination.
    Intern Med. 2022 Jul 14. doi: 10.2169/internalmedicine.0372.
    PubMed        

  9. UZAWA A, Mori M, Iwai Y, Masuda H, et al
    Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment.
    Intern Med. 2022 Feb 8. doi: 10.2169/internalmedicine.9036.
    PubMed         Abstract available


    J Autoimmun

  10. EFE C, Tascilar K, Gerussi A, Bolis F, et al
    SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis.
    J Autoimmun. 2022;132:102906.
    PubMed         Abstract available


    J Nephrol

  11. XU L, Kant S, Aqeel F, Antiochos B, et al
    Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    J Nephrol. 2022 Sep 9. pii: 10.1007/s40620-022-01460.
    PubMed        


    J Neuroimmunol

  12. BEECHER G, Howe BM, Shelly S, Staff NP, et al
    Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMN.
    J Neuroimmunol. 2022;371:577953.
    PubMed         Abstract available

  13. FEIZI P, Sharma K, Pasham SR, Nirwan L, et al
    Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review.
    J Neuroimmunol. 2022;371:577939.
    PubMed         Abstract available


    J Neurol

  14. KOCH MW, Mostert J, Repovic P, Bowen JD, et al
    The timed 25-foot walk is a more sensitive outcome measure than the EDSS for PPMS trials: an analysis of the PROMISE clinical trial dataset.
    J Neurol. 2022;269:5319-5327.
    PubMed         Abstract available

  15. REYES-VEGA MF, Soto-Cabezas MG, Soriano-Moreno AN, Valle-Campos A, et al
    Clinical features of Guillain-Barre syndrome and factors associated with mortality during the 2019 outbreak in Peru.
    J Neurol. 2022 Sep 13. pii: 10.1007/s00415-022-11331.
    PubMed         Abstract available

  16. NICOLAS P, Marion-Moffet H, Gossez M, Vukusic S, et al
    Anti-SARS-CoV-2 humoral and cellular responses in multiple sclerosis patients treated with anti-CD20 monoclonal antibodies.
    J Neurol. 2022 Sep 12. pii: 10.1007/s00415-022-11353.
    PubMed        

  17. MAIER A, Kapfenberger R, Katona I, Weis J, et al
    Nonregional small fibre neuropathy in cases of autoimmune autonomic neuropathy.
    J Neurol. 2022 Sep 9. pii: 10.1007/s00415-022-11340.
    PubMed         Abstract available

  18. LEVI-STRAUSS J, Provost C, Wane N, Jacquemont T, et al
    NMOSD typical brain lesions after COVID-19 mRNA vaccination.
    J Neurol. 2022;269:5213-5215.
    PubMed        

  19. KANG L, Wan C
    Paraneoplastic syndrome in neuroophthalmology.
    J Neurol. 2022;269:5272-5282.
    PubMed         Abstract available

  20. COSTELLO F, Burton JM
    Contemporary management challenges in seropositive NMOSD.
    J Neurol. 2022;269:5674-5681.
    PubMed         Abstract available


    J Pediatr Endocrinol Metab

  21. POON SW, Tung JY, Wong WH, Cheung PT, et al
    Diabetic ketoacidosis in children with new-onset type 1 diabetes mellitus: demographics, risk factors and outcome: an 11 year review in Hong Kong.
    J Pediatr Endocrinol Metab. 2022;35:1132-1140.
    PubMed         Abstract available

  22. CHIKANI UN, Ohuche IO, Dike CM
    Pattern of presentation of paediatric endocrine disorders in a Nigerian tertiary institution: an 11-year survey.
    J Pediatr Endocrinol Metab. 2022;35:1183-1188.
    PubMed         Abstract available


    Kidney Int

  23. KURIEN AA, Jansi Prema KS, Walker P, Caza T, et al
    Traditional indigenous medicines are an etiologic consideration for NELL1-positive membranous nephropathy.
    Kidney Int. 2022 Sep 9. pii: S0085-2538(22)00712.
    PubMed        

  24. LUO C, Ouyang Y, Shi S, Li G, et al
    Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy.
    Kidney Int. 2022 Sep 7. pii: S0085-2538(22)00696.
    PubMed         Abstract available

  25. DIEBOLD M, Locher E, Boide P, Enzler-Tschudy A, et al
    Incidence of new onset glomerulonephritis after SARS-CoV-2 mRNA vaccination is not increased.
    Kidney Int. 2022 Sep 9. pii: S0085-2538(22)00697.
    PubMed         Abstract available


    N Engl J Med

  26. BOLINDER J
    CLOuDs Disperse - Top-Notch Glucose Control and Residual C-Peptide Secretion.
    N Engl J Med. 2022;387:937-938.
    PubMed        

  27. BOUGHTON CK, Allen JM, Ware J, Wilinska ME, et al
    Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes.
    N Engl J Med. 2022;387:882-893.
    PubMed         Abstract available

  28. WINGERCHUK DM, Lucchinetti CF
    Neuromyelitis Optica Spectrum Disorder.
    N Engl J Med. 2022;387:631-639.
    PubMed        

  29. BURNSIDE MJ, Lewis DM, Crocket HR, Meier RA, et al
    Open-Source Automated Insulin Delivery in Type 1 Diabetes.
    N Engl J Med. 2022;387:869-881.
    PubMed         Abstract available


    Nat Rev Neurol

  30. JACOBS BM, Peter M, Giovannoni G, Noyce AJ, et al
    Towards a global view of multiple sclerosis genetics.
    Nat Rev Neurol. 2022 Sep 8. pii: 10.1038/s41582-022-00704.
    PubMed         Abstract available


    Neurology

  31. GANESH A, Galetta S
    Editors' Note: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:489.
    PubMed        

  32. VALE S
    Reader Response: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:491.
    PubMed        

  33. GUASP M, Dalmau J
    Author Response: Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Neurology. 2022;99:490.
    PubMed        

  34. CAROTENUTO A, Valsasina P, Schoonheim MM, Geurts JJ, et al
    Investigating Functional Network Abnormalities and Associations With Disability in Multiple Sclerosis.
    Neurology. 2022 Sep 12. pii: WNL.0000000000201264.
    PubMed         Abstract available


    PLoS Biol

  35. SMITH KJ, Minns D, McHugh BJ, Holloway RK, et al
    The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.
    PLoS Biol. 2022;20:e3001554.
    PubMed         Abstract available


    PLoS One

  36. VIROONLUECHA P, Egea-Lopez E, Santa J
    Evaluation of blood glucose level control in type 1 diabetic patients using deep reinforcement learning.
    PLoS One. 2022;17:e0274608.
    PubMed         Abstract available

  37. TAKASHI Y, Maeda Y, Toyokawa K, Oda N, et al
    Fibroblast growth factor 23 and kidney function in patients with type 1 diabetes.
    PLoS One. 2022;17:e0274182.
    PubMed         Abstract available

  38. JOH K, Nakazato T, Hashiguchi A, Shimizu A, et al
    Structural modeling for Oxford histological classifications of immunoglobulin A nephropathy.
    PLoS One. 2022;17:e0268731.
    PubMed         Abstract available

  39. LAROCQUE JC, Gardy S, Sammut M, McBey DP, et al
    Sexual dimorphism in response to repetitive bouts of acute aerobic exercise in rodents with type 1 diabetes mellitus.
    PLoS One. 2022;17:e0273701.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: